ATE473757T1 - Stabile glucoseoxidase-formulierungen und verfahren zur herstellung und verwendung davon - Google Patents

Stabile glucoseoxidase-formulierungen und verfahren zur herstellung und verwendung davon

Info

Publication number
ATE473757T1
ATE473757T1 AT06718158T AT06718158T ATE473757T1 AT E473757 T1 ATE473757 T1 AT E473757T1 AT 06718158 T AT06718158 T AT 06718158T AT 06718158 T AT06718158 T AT 06718158T AT E473757 T1 ATE473757 T1 AT E473757T1
Authority
AT
Austria
Prior art keywords
formulations
methods
glucose oxidase
production
stable glucose
Prior art date
Application number
AT06718158T
Other languages
English (en)
Inventor
Poonam Gulati
Sarnath Chattaraj
Elango Minnoor
Eugene Levin
Xiao Zhu
Antwerp William Van
Original Assignee
Medtronic Minimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Minimed Inc filed Critical Medtronic Minimed Inc
Application granted granted Critical
Publication of ATE473757T1 publication Critical patent/ATE473757T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/443Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/74Optical detectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/12Manufacturing methods specially adapted for producing sensors for in-vivo measurements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1468Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1486Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/902Oxidoreductases (1.)
    • G01N2333/904Oxidoreductases (1.) acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT06718158T 2005-02-17 2006-01-12 Stabile glucoseoxidase-formulierungen und verfahren zur herstellung und verwendung davon ATE473757T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/060,255 US7241586B2 (en) 2005-02-17 2005-02-17 Polypeptide formulations and methods for making, using and characterizing them
PCT/US2006/001048 WO2006088576A2 (en) 2005-02-17 2006-01-12 Polypeptide formulations and methods for making, using and characterizing them

Publications (1)

Publication Number Publication Date
ATE473757T1 true ATE473757T1 (de) 2010-07-15

Family

ID=36423621

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06718158T ATE473757T1 (de) 2005-02-17 2006-01-12 Stabile glucoseoxidase-formulierungen und verfahren zur herstellung und verwendung davon

Country Status (8)

Country Link
US (2) US7241586B2 (de)
EP (1) EP1851536B1 (de)
JP (1) JP4948424B2 (de)
AT (1) ATE473757T1 (de)
CA (1) CA2597367C (de)
DE (1) DE602006015427D1 (de)
DK (1) DK1851536T3 (de)
WO (1) WO2006088576A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8527026B2 (en) 1997-03-04 2013-09-03 Dexcom, Inc. Device and method for determining analyte levels
US6001067A (en) 1997-03-04 1999-12-14 Shults; Mark C. Device and method for determining analyte levels
US20030032874A1 (en) 2001-07-27 2003-02-13 Dexcom, Inc. Sensor head for use with implantable devices
US8364229B2 (en) 2003-07-25 2013-01-29 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US7828728B2 (en) 2003-07-25 2010-11-09 Dexcom, Inc. Analyte sensor
US7613491B2 (en) 2002-05-22 2009-11-03 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
EP1648298A4 (de) 2003-07-25 2010-01-13 Dexcom Inc Sauerstoffverbessernde membransysteme für implantierbare vorrichtungen
US9763609B2 (en) 2003-07-25 2017-09-19 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US8277713B2 (en) 2004-05-03 2012-10-02 Dexcom, Inc. Implantable analyte sensor
US8989833B2 (en) 2004-07-13 2015-03-24 Dexcom, Inc. Transcutaneous analyte sensor
US20070045902A1 (en) 2004-07-13 2007-03-01 Brauker James H Analyte sensor
US8886272B2 (en) 2004-07-13 2014-11-11 Dexcom, Inc. Analyte sensor
US8744546B2 (en) 2005-05-05 2014-06-03 Dexcom, Inc. Cellulosic-based resistance domain for an analyte sensor
US20200037875A1 (en) 2007-05-18 2020-02-06 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US8512731B2 (en) * 2007-11-13 2013-08-20 Medtronic Minimed, Inc. Antimicrobial coatings for medical devices and methods for making and using them
US20090275815A1 (en) * 2008-03-21 2009-11-05 Nova Biomedical Corporation Temperature-compensated in-vivo sensor
US8583204B2 (en) 2008-03-28 2013-11-12 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US8682408B2 (en) 2008-03-28 2014-03-25 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US11730407B2 (en) 2008-03-28 2023-08-22 Dexcom, Inc. Polymer membranes for continuous analyte sensors
EP4549933A3 (de) 2008-09-19 2025-05-21 DexCom, Inc. Partikelhaltige membran und partikelelektrode für analytsensoren
WO2010099507A1 (en) * 2009-02-26 2010-09-02 Abbott Diabetes Care Inc. Improved analyte sensors and methods of making and using the same
US9237864B2 (en) 2009-07-02 2016-01-19 Dexcom, Inc. Analyte sensors and methods of manufacturing same
CN102749408B (zh) * 2011-04-21 2015-08-19 天士力金纳生物技术(天津)有限公司 一种亚单位流感疫苗中裂解剂含量的检测方法
CN104458969B (zh) * 2014-12-31 2016-05-11 深圳康泰生物制品股份有限公司 重组酿酒酵母表达的HBsAg原液中Triton X-100残留量的测定方法
HRP20250718T1 (hr) * 2016-08-15 2025-08-15 F. Hoffmann-La Roche Ag Kromatografski postupak za kvantifikaciju neionskog surfaktanta u sastavu koji sadrži neionski surfaktant i polipeptid
CN109406698B (zh) * 2018-11-30 2020-12-25 广州中科检测技术服务有限公司 一种hplc测定单链取代二甲基苄基氯化铵含量的方法
JP7732996B2 (ja) * 2020-03-20 2025-09-02 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド ポリソルベートを検出する方法
CN112710751A (zh) * 2020-12-19 2021-04-27 无锡济煜山禾药业股份有限公司 一种醒脑静注射液中吐温80含量测定方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2308013A1 (de) * 1973-02-17 1974-09-12 Behringwerke Ag Katalasearme glucoseoxidase und verfahren zu ihrer gewinnung
US4045343A (en) 1975-11-10 1977-08-30 Varian Associates, Inc. High pressure liquid chromatography system
US4116837A (en) 1978-01-12 1978-09-26 The Upjohn Company High pressure liquid chromatography apparatus
EP0021817B1 (de) * 1979-06-22 1985-10-02 Sekisui Kagaku Kogyo Kabushiki Kaisha Füllmaterial für Flüssigkeits-Chromatographie, Verfahren zur Trennung wasserlöslicher Substanzen mit diesem Füllstoff und Verwendung dieses Füllstoffes bei der Trennung wasserlöslicher biochemischer Substanzen
US4729959A (en) * 1986-02-24 1988-03-08 Streck Laboratories, Inc. Glucose reference control for glucose test strips
US4952321A (en) 1988-10-07 1990-08-28 Brigham Young University Process of removing and concentrating desired ions from solutions
ZA938555B (en) 1992-11-23 1994-08-02 Lilly Co Eli Technique to improve the performance of electrochemical sensors
DK0641859T3 (da) * 1993-09-01 2004-03-29 Genencor Int Fremgangsmåde til fremstilling af immobiliserede enzymkonjugater og immobiliserede enzymkonjugater fremstillet derved
US5447556A (en) 1994-03-04 1995-09-05 Graseby-Anderson, Inc. Sample injection apparatus and method
US5670054A (en) 1996-04-04 1997-09-23 Warner Lambert Company Method and system for identification, purification, and quantitation of reaction components
GB9618428D0 (en) 1996-09-04 1996-10-16 Polymer Lab Ltd ELSD diffuser
DE19652713C2 (de) 1996-12-18 2001-11-22 Aventis Pharma Gmbh Verfahren zur Reinigung von Insulin und Insulinderivaten durch Chromatographie an stark saurem Kationenaustauscher
US5938932A (en) 1997-11-14 1999-08-17 Pharmacopeia, Inc. High-throughput method and apparatus for identifying, quantitating and determining the purity of chemical compounds in mixtures
JP3694424B2 (ja) * 1998-09-29 2005-09-14 松下電器産業株式会社 グルコースセンサ
US6280623B1 (en) 1999-03-23 2001-08-28 Hsien-Chih Ma Differential and continuous separation apparatus with controlled parameters for solids and liquids
US6541273B1 (en) 1999-11-12 2003-04-01 Aventis Cropscience, S.A. Multiple sorbent cartridges for solid phase extraction
US6229605B1 (en) * 2000-03-10 2001-05-08 Alltech Associates, Inc. Evaporative light scattering device
US6759442B2 (en) 2000-06-02 2004-07-06 Showa Denko Kabushiki Kaisha Packing material for solid phase extraction and solid phase extraction method
US6602928B2 (en) 2000-08-21 2003-08-05 Showa Denko Kabushiki Kaisha Packing material and cartridge for solid phase extraction
US6465411B2 (en) * 2000-12-21 2002-10-15 Clariant International Ltd. Pine oil cleaning composition
US6679989B2 (en) 2001-06-01 2004-01-20 Agilent Technologies, Inc. Integral, thru-bore, direct coupled high pressure liquid chromatography guard column
US6737401B2 (en) 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
US20030077702A1 (en) * 2001-10-23 2003-04-24 Rajiv Shah Method for formulating a glucose oxidase enzyme with a desired property or properties and a glucose oxidase enzyme with the desired property
US6723236B2 (en) 2002-03-19 2004-04-20 Waters Investments Limited Device for solid phase extraction and method for purifying samples prior to analysis
US20040074785A1 (en) 2002-10-18 2004-04-22 Holker James D. Analyte sensors and methods for making them
JP2004212393A (ja) * 2002-12-20 2004-07-29 Matsushita Electric Ind Co Ltd バイオセンサ
ES2292927T3 (es) * 2003-01-16 2008-03-16 Adorkem Technology Spa Biocatalizadores inmovilizados utilizables para la produccion de nucleosidos naturales y de analogos modificados a traves de reacciones enzimaticas de transglicosilacion.

Also Published As

Publication number Publication date
CA2597367C (en) 2013-06-25
WO2006088576A2 (en) 2006-08-24
DK1851536T3 (da) 2010-10-25
EP1851536A2 (de) 2007-11-07
JP2008536097A (ja) 2008-09-04
DE602006015427D1 (de) 2010-08-26
US7241586B2 (en) 2007-07-10
US20080113443A1 (en) 2008-05-15
JP4948424B2 (ja) 2012-06-06
EP1851536B1 (de) 2010-07-14
CA2597367A1 (en) 2006-08-24
WO2006088576A3 (en) 2007-02-08
US20060183178A1 (en) 2006-08-17

Similar Documents

Publication Publication Date Title
ATE473757T1 (de) Stabile glucoseoxidase-formulierungen und verfahren zur herstellung und verwendung davon
ATE500509T1 (de) Faseroptik zum abtasten von analyten und herstellungsverfahren dafür
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DK1969359T3 (da) Biosensorer og fremgangsmåde til fremstilling og anvendelse heraf
DE602005022471D1 (de) Zusammensetzungen enthaltend lipase, protease und amylase zur behandlung von pankreasinsuffizienz
DE60314500D1 (de) Diaminopyrimidine und deren verwendung als angiogenesehemmer
BRPI0813699A2 (pt) Formulações de proteína de fusão glp-1-fc
SG162788A1 (en) Self-buffering protein formulations
WO2008046003A3 (en) Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
BRPI0507680A (pt) partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas
GT200600112A (es) Composiciiones de tigeciclina y metodos de preparacion
PL1979474T3 (pl) Ptasia odwrotna transkryptaza o charakterze telomerazy
BRPI0923015A2 (pt) enxertos ósseos com atividade de protease reduzida e métodos de seleção e uso
WO2009013461A8 (en) Growth hormone fusion proteins
ATE477798T1 (de) Verwendung von agomelatin zur herstellung von medikamenten zur behandlung der generalisierten angststörung
WO2008014135A3 (en) Non-invasive analyte measurement glasses and method of use
ATE544462T1 (de) Verwendung des epidermalen wachstumsfaktors zur morphofunktionellen wiederherstellung von peripheren nerven bei diabetischer neuropathie
DE602005001688D1 (de) Aufbereitung von Aldesleukin zur pharmazeutischen Verwendung
EA200970597A1 (ru) Новые бис(диалкиламиды), способ получения и применения
EP2975134A3 (de) Kristallstruktur einer humanen alpha-n-acetylglucosaminidase
ATE536167T1 (de) Zusammensetzung zur förderung der kollagenproduktion
ATE504595T1 (de) Il-22 zur behandlung von fettleibigkeit, diabetes,hyperlipidämie, hyperglykämie und insulinresistenz
ATE471171T1 (de) Chirurgische einrichtung zur entnahme von gewebezellen aus einer biologischen struktur insbesondere zur liposuktion
DK2167676T3 (da) Kit til sekventiel måling af (1) den enzymatisk aktive fraktion og (2) den samlede mængde af et enzym
TW200716159A (en) Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties